Pascal Medical AB develops products for the treatment of Meni��re��s disease, an inner ear disorder. It operates in conjunction with Swedish as well as international ear, nose, and throat clinics, and supplies its patented product under the brand name Meniett. The company was founded in 1996 and is headquartered in Halmstad, Sweden.

While working at Pharmacia in the late 80’s Johan Stjernschantz was the co-inventor of latanoprost, a prostaglandin F2α receptor agonist, and the therapeutic principle behind Xalatan® which radically improved the treatment of glaucoma. He was also in charge of the entire development of Xalatan®, including the regulatory approval in Europe and the USA.

Otonomy is an expert in the otology field in order to build the premier company dedicated to the treatment of otic disorders via localized drug delivery. This approach has already been widely adopted for the delivery of short-acting antibiotics to treat otitis media through a tympanostomy tube. In addition, otolaryngologists have demonstrated that the injection of steroids into the middle ear cavity can provide a therapeutic effect for patients with acute inner ear disorders such as Ménière’s disease and sudden sensorineural hearing loss. Expansion of this effort holds great promise for the treatment of chronic hearing loss, severe vertigo, and even tinnitus. The key to Otonomy's leading position in this nascent field is the development of a proprietary formulation platform that provides sustained drug exposure from a single administration. Broad application of this technology has already been established across a number of therapeutic classes, and from these, three product candidates have been advanced into development.

Sanwa Kagaku Kenkyusho Co., Ltd. engages in the research, development, manufacture, and marketing of pharmaceuticals, diagnostics, medical and nursing care nutritionals, and healthcare products. The company also provides contract manufacturing services for pharmaceuticals. It offers products through a network of medical representatives worldwide. The company was founded in 1953 and is based in Nagoya, Japan. Sanwa Kagaku Kenkyusho Co., Ltd. operates as a subsidiary of Suzuken Co., Ltd.

Decibel Therapeutics, Inc. discovers and develops medicines to protect, repair, and restore hearing. The firm focuses on hearing disorders, including noise-induced hearing loss, residual hearing preservation or improved sound fidelity with cochlear implants, presbycusis or age-related hearing loss, tinnitus, a persistent ringing in the ears, and genetic hearing loss. It also offers drugs for pediatric cancer and cystic fibrosis patients who experience ototoxicity or hearing loss. The company was founded in October 2015 and is headquartered in Boston, MA.

Neurogen Corporation is a drug development company historically focusing on small-molecule drugs to improve the lives of patients suffering from psychiatric and neurological disorders with significant unmet medical need. Neurogen has conducted its drug development independently and, when advantageous, collaborated with world-class pharmaceutical companies to access additional resources and expertise.

Ovid is a pure play neurology company focused on rare and orphan diseases of the brain. They were founded in 2014 to leverage recent advances in science and medicine to find optimal therapies. They seek to identify and develop late stage, de-risked medicines with significant potential. Their rationale for developing these medicines is based on key insights from their scientific founders and confirmed in discussions with leading experts in the field. Their products are protected by strong intellectual property. They apply the most efficient processes to bring safe and effective therapies to patients. They are based in New York City but have collaborators and are working with patients across the United States and the globe.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Inspire Pharmaceuticals, Inc. is a biopharmaceutical company focused on researching, developing and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases. The advanced compounds in the clinical pipeline are denufosol tetrasodium for cystic fibrosis and Prolacria for dry eye, both of which are in Phase III development, and AzaSite for blepharitis, which is in Phase II development.

Beijing Aohe Pharmaceutical Research Institute Co., Ltd., established on 2010-05-12, Business scope includes medical research and experimental development;Health Advisory;Import and export,Technology Import and Export,Agent import and export;technology development,technology transfer,technical consulting,Technical Services;Technical testing.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Conba Group Co., Ltd. is a Chinese private company located in Hangzhou, with operations in CN. The firm develops and manufactures pharmaceutical products.

Shaanxi Buchang Pharmaceutical Co., Ltd., established on 2009-11-19, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Chinese herbal medicine planting(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:pharmaceutical production;Drug Wholesale;Pharmaceutical commissioned production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Beijing Lansheng Pharmaceutical Technology Co., Ltd., established on 2014-03-21, Business scope includes technology development,technology transfer,Technical Services,technical consulting;buisness planning.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Spiral Therapeutics, Inc. manufactures pharmaceutical products. The firm also develops therapies for inner ear disorders. The company was founded by Hugo Peris, Justin S. Hanes and Eugene de Juan in 2016 and is headquartered in San Francisco, CA.

Otsuka Holdings operates in pharmaceuticals, nutraceuticals, and consumer products. The business activity of the company includes providing healthcare solutions in the areas of the nervous system, oncology, cardiovascular system, respiratory system, infectious disease, and others. The company engages in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks, and dietary foods.

Huzhou Pinchuang Incubator Co., Ltd., established on 2012-05-18, Business scope includes general items:Entrepreneurial Space Services;Trademark agency;copyright agent;Business Management Consulting;Corporate Image Planning;Technology intermediary service;Information Consulting Service(Not including licensing information consulting services);Intellectual Property Services(Except for patent agency services)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Guangxi Shentong Pharmaceutical Co., Ltd., established on 1999-04-28, The business scope includes granules,hard capsule,tablet(Contains traditional Chinese medicine pretreatment and extraction),oral liquid,Syrup production,Sales;Chinese herbal medicine acquisition.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Anida Pharma, Inc. is a biopharmaceutical company developing new therapies for orphan neurological indications with a focus on pediatric indications: retinopathy of prematurity (ROP), brain injury of the newborn (hypoxic-ischemic encephalopathy; HIE), and drug-induced hearing loss. Anida also has a program for the treatment of amyotrophic lateral sclerosis (ALS; Lou Gehrig disease).

AudioCure Pharma is a pharmaceutical company with a focus on hearing impairments. Operational since 2012, AudioCure was founded by Professor Hans Rommelspacher; a clinician and academic who has dedicated his career to the discovery and preclinical development of drug candidates. He is joined by highly skilled scientists and executives as well as a tight-knit network of academic partners, internationally renowned advisors and strategic investors. AudioCure is based in Berlin, Germany. Their office is located in a peaceful courtyard in the central area of Mitte. As such, they benefit from being within easy reach of the main train station and many other Berlin high-tech companies and universities while also enjoying the hustle and bustle of this vibrant capital city. They have close ties to the Charité University which allows for a close interaction with the experts of this world renowned institution. Their front-runner compound: AC102, is currently in late stage preclinical development for the treatment of acute noise-induced hearing loss having successfully demonstrated preclinical proof of concept in 2016.

Jiaxing Yatang Technology Co., Ltd., established on 2017-08-10, Business scope includes computer software and hardware,smart device,construction equipment,network technology,e-commerce technology,new material,Technology development of environmental protection equipment,technical consulting,Technical Services,Achievement transfer.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)